Announced Mon, 4 May · 15:15 IST
Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board & Shareholder Meetings View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹162.00
prior close
₹160.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2——-1.3+1.8+13.3+10.9+13.6+9.3+10.7+4.8+9.9—
Up moveDown movePending
AI summary
Piramal Pharma Ltd has filed a disclosure with BSE informing about a scheduled analyst or institutional investor meeting, as required under SEBI's Listing Regulations. The actual document content (meeting date, time, venue, and participants) was not accessible due to a page error on the BSE portal. Such filings are routine obligations for listed companies to maintain transparency about investor interactions.
Likely market impact
No direct share price impact. Routine disclosure — confirms the company is engaging with institutional investors as per regulatory norms.